Cargando…
Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis
BACKGROUND/AIMS: The most widely used method for diagnosing sarcopenia is the skeletal muscle index (SMI). Several studies have suggested that psoas muscle thickness per height (PMTH) is also effective for detecting sarcopenia and predicting prognosis in patients with cirrhosis. The aim of this stud...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166111/ https://www.ncbi.nlm.nih.gov/pubmed/29706058 http://dx.doi.org/10.3350/cmh.2017.0077 |
_version_ | 1783359974193233920 |
---|---|
author | Gu, Dae Hoe Kim, Moon Young Seo, Yeon Seok Kim, Sang Gyune Lee, Han Ah Kim, Tae Hyung Jung, Young Kul Kandemir, Altay Kim, Ji Hoon An, Hyunggin Yim, Hyung Joon Yeon, Jong Eun Byun, Kwan Soo Um, Soon Ho |
author_facet | Gu, Dae Hoe Kim, Moon Young Seo, Yeon Seok Kim, Sang Gyune Lee, Han Ah Kim, Tae Hyung Jung, Young Kul Kandemir, Altay Kim, Ji Hoon An, Hyunggin Yim, Hyung Joon Yeon, Jong Eun Byun, Kwan Soo Um, Soon Ho |
author_sort | Gu, Dae Hoe |
collection | PubMed |
description | BACKGROUND/AIMS: The most widely used method for diagnosing sarcopenia is the skeletal muscle index (SMI). Several studies have suggested that psoas muscle thickness per height (PMTH) is also effective for detecting sarcopenia and predicting prognosis in patients with cirrhosis. The aim of this study was to evaluate the optimal cutoff values of PMTH for detecting sarcopenia in cirrhotic patients. METHODS: All cirrhotic patients who underwent abdominal computed tomography (CT) scan including L3 and umbilical levels for measuring SMI and transverse psoas muscle thickness, respectively, were included. Two definitions of sarcopenia were used: (1) sex-specific cutoffs of SMI (≤52.4 cm(2) /m(2) in men and ≤38.5 cm(2) /m(2) in women) for SMI-sarcopenia and (2) cutoff of PMTH (<16.8 mm/m) for PMTH-sarcopenia. RESULTS: Six hundred fifty-three patients were included. The average age was 53.6 ± 10.2 years, and 499 patients (76.4%) were men. PMTH correlated well with SMI in both men and women (P<0.001). Two hundred forty-one (36.9%) patients met the criteria for SMI-sarcopenia. The best PMTH cutoff values for predicting SMI-sarcopenia were 17.3 mm/m in men and 10.4 mm/m in women, and these were defined as sex-specific cutoffs of PMTH (SsPMTH). The previously published cutoff of PMTH was defined as sex-nonspecific cutoff of PMTH (SnPMTH). Two hundred thirty (35.2%) patients were diagnosed with SsPMTH-sarcopenia, and 280 (44.4%) patients were diagnosed with SnPMTH-sarcopenia. On a multivariate Cox regression analysis, SsPMTH-sarcopenia (hazard ratio [HR], 1.944; 95% confidence interval [CI], 1.144–3.304; P=0.014) was significantly associated with mortality, while SnPMTH-sarcopenia was not (HR, 1.446; 95% CI, 0.861–2.431; P=0.164). CONCLUSIONS: PMTH was well correlated with SMI in cirrhotic patients. SsPMTH-sarcopenia was an independent predictor of mortality in these patients and more accurately predicted mortality compared to SnPMTH-sarcopenia. |
format | Online Article Text |
id | pubmed-6166111 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Korean Association for the Study of the Liver |
record_format | MEDLINE/PubMed |
spelling | pubmed-61661112018-10-04 Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis Gu, Dae Hoe Kim, Moon Young Seo, Yeon Seok Kim, Sang Gyune Lee, Han Ah Kim, Tae Hyung Jung, Young Kul Kandemir, Altay Kim, Ji Hoon An, Hyunggin Yim, Hyung Joon Yeon, Jong Eun Byun, Kwan Soo Um, Soon Ho Clin Mol Hepatol Original Article BACKGROUND/AIMS: The most widely used method for diagnosing sarcopenia is the skeletal muscle index (SMI). Several studies have suggested that psoas muscle thickness per height (PMTH) is also effective for detecting sarcopenia and predicting prognosis in patients with cirrhosis. The aim of this study was to evaluate the optimal cutoff values of PMTH for detecting sarcopenia in cirrhotic patients. METHODS: All cirrhotic patients who underwent abdominal computed tomography (CT) scan including L3 and umbilical levels for measuring SMI and transverse psoas muscle thickness, respectively, were included. Two definitions of sarcopenia were used: (1) sex-specific cutoffs of SMI (≤52.4 cm(2) /m(2) in men and ≤38.5 cm(2) /m(2) in women) for SMI-sarcopenia and (2) cutoff of PMTH (<16.8 mm/m) for PMTH-sarcopenia. RESULTS: Six hundred fifty-three patients were included. The average age was 53.6 ± 10.2 years, and 499 patients (76.4%) were men. PMTH correlated well with SMI in both men and women (P<0.001). Two hundred forty-one (36.9%) patients met the criteria for SMI-sarcopenia. The best PMTH cutoff values for predicting SMI-sarcopenia were 17.3 mm/m in men and 10.4 mm/m in women, and these were defined as sex-specific cutoffs of PMTH (SsPMTH). The previously published cutoff of PMTH was defined as sex-nonspecific cutoff of PMTH (SnPMTH). Two hundred thirty (35.2%) patients were diagnosed with SsPMTH-sarcopenia, and 280 (44.4%) patients were diagnosed with SnPMTH-sarcopenia. On a multivariate Cox regression analysis, SsPMTH-sarcopenia (hazard ratio [HR], 1.944; 95% confidence interval [CI], 1.144–3.304; P=0.014) was significantly associated with mortality, while SnPMTH-sarcopenia was not (HR, 1.446; 95% CI, 0.861–2.431; P=0.164). CONCLUSIONS: PMTH was well correlated with SMI in cirrhotic patients. SsPMTH-sarcopenia was an independent predictor of mortality in these patients and more accurately predicted mortality compared to SnPMTH-sarcopenia. The Korean Association for the Study of the Liver 2018-09 2018-04-30 /pmc/articles/PMC6166111/ /pubmed/29706058 http://dx.doi.org/10.3350/cmh.2017.0077 Text en Copyright © 2018 by The Korean Association for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Gu, Dae Hoe Kim, Moon Young Seo, Yeon Seok Kim, Sang Gyune Lee, Han Ah Kim, Tae Hyung Jung, Young Kul Kandemir, Altay Kim, Ji Hoon An, Hyunggin Yim, Hyung Joon Yeon, Jong Eun Byun, Kwan Soo Um, Soon Ho Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis |
title | Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis |
title_full | Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis |
title_fullStr | Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis |
title_full_unstemmed | Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis |
title_short | Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis |
title_sort | clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166111/ https://www.ncbi.nlm.nih.gov/pubmed/29706058 http://dx.doi.org/10.3350/cmh.2017.0077 |
work_keys_str_mv | AT gudaehoe clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis AT kimmoonyoung clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis AT seoyeonseok clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis AT kimsanggyune clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis AT leehanah clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis AT kimtaehyung clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis AT jungyoungkul clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis AT kandemiraltay clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis AT kimjihoon clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis AT anhyunggin clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis AT yimhyungjoon clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis AT yeonjongeun clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis AT byunkwansoo clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis AT umsoonho clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis |